https://orcid.org/0000-0003-1803-2046
Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Matteo Megna, Luca Potestio, Gabriella Fabbrocini & Angelo Ruggiero. (2022) Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study. Psoriasis: Targets and Therapy 12, pages 205-212.
Read now
Read now
Angelo Ruggiero, Luca Potestio, Elisa Camela, Gabriella Fabbrocini & Matteo Megna. (2022) Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge. Psoriasis: Targets and Therapy 12, pages 127-137.
Read now
Read now
Angelo Ruggiero, Vincenzo Picone, Fabrizio Martora, Gabriella Fabbrocini & Matteo Megna. (2022) Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence. Clinical, Cosmetic and Investigational Dermatology 15, pages 1649-1658.
Read now
Read now
Justyna Ceryn, Michał Niedźwiedź, Małgorzata Skibińska, Magdalena Ciążyńska, Aleksandra Lesiak & Joanna Narbutt. (2021) COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review. Clinical, Cosmetic and Investigational Dermatology 14, pages 1131-1138.
Read now
Read now
Articles from other publishers (15)
Katrina Dovalovsky, Carolina Puyana & Maria M. Tsoukas. (2023) Hidradenitis suppurativa perspectives during the COVID-19 pandemic. Clinics in Dermatology 41:5, pages 622-627.
Crossref
Crossref
Angelo Ruggiero, Claudio Marasca, Gabriella Fabbrocini, Alessia Villani & Fabrizio Martora. (2022) Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?. Journal of Cosmetic Dermatology 22:2, pages 677-678.
Crossref
Crossref
Angelo Ruggiero, Alessia Villani, Gabriella Fabbrocini & Fabrizio Martora. (2022) Reply to: “Usage and perceptions of teledermatology in 2021: a survey of dermatologists” by Ahmad et al.. International Journal of Dermatology 62:2.
Crossref
Crossref
Angelo Ruggiero, Matteo Megna, Gabriella Fabbrocini & Sonia Sofia Ocampo-Garza. (2023) Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data. Immunologic Research.
Crossref
Crossref
Fabrizio Martora, Claudio Marasca, Teresa Battista, Gabriella Fabbrocini & Angelo Ruggiero. (2022) Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: ‘Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa’. Clinical and Experimental Dermatology 47:11, pages 2026-2028.
Crossref
Crossref
Angelo Ruggiero, Claudio Marasca, Alessia Villani, Gabriella Fabbrocini & Fabrizio Martora. (2022) Tacrolimus ointment may improve the effectiveness of adalimumab in patients with hidradenitis suppurativa: a novel promising treatment. Clinical and Experimental Dermatology 47:10, pages 1871-1872.
Crossref
Crossref
Angelo Ruggiero, Matteo Megna, Gabriella Fabbrocini & Fabrizio Martora. (2022) Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concerns. Clinical and Experimental Dermatology 47:10, pages 1863-1864.
Crossref
Crossref
Fabrizio Martora, Gabriella Fabbrocini, Lucia Gallo & Ruggiero Angelo. (2022) Comment on ‘Unexpected consequences of SARS-CoV-2 pandemic: scabies infestation’. Clinical and Experimental Dermatology 47:10, pages 1862-1862.
Crossref
Crossref
Matteo Megna, Luca Potestio, Elisa Camela, Gabriella Fabbrocini & Angelo Ruggiero. (2022) Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single‐center retrospective study in a real‐life setting. Dermatologic Therapy 35:9.
Crossref
Crossref
Fabrizio Martora, Vincenzo Picone, Teresa Battista, Gabriella Fabbrocini & Claudio Marasca. (2022)
Reply to “the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea‐like eruptions following
COVID
‐19 vaccinations” by Ciccarese G. et al.
. Dermatologic Therapy 35:8.
Crossref
Crossref
Vikash Paudel. (2022) Patterns and barriers of teledermatology in resource-limited settings in COVID-19 pandemic: A descriptive cross-sectional survey of Nepalese dermatologists. JAAD International 7, pages 62-66.
Crossref
Crossref
Elia Rosi, Maria Thais Fastame, Antonella Di Cesare, Gianmarco Silvi, Nicola Pimpinelli & Francesca Prignano. (2021) Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic. Journal of Clinical Medicine 10:24, pages 5841.
Crossref
Crossref
J. Beecker, K.A. Papp, J. Dutz, R.B. Vender, R. Gniadecki, C. Cooper, P. Gisondi, M. Gooderham, C.H. Hong, M.G. Kirchhof, C.W. Lynde, C. Maari, Y. Poulin & L. Puig. (2021) Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond. Journal of the European Academy of Dermatology and Venereology 35:4, pages 797-806.
Crossref
Crossref
Christos C. Zouboulis, Farida Benhadou, Angel S. Byrd, Nisha S. Chandran, Evangelos J. Giamarellos‐Bourboulis, Gabriella Fabbrocini, John W. Frew, Hideki Fujita, Marcos A. González‐López, Philippe Guillem, Wayne P. F. Gulliver, Iltefat Hamzavi, Yildiz Hayran, Barbara Hórvath, Sophie Hüe, Robert E. Hunger, John R. Ingram, Gregor B.E. Jemec, Qiang Ju, Alexa B. Kimball, Joslyn S. Kirby, Maria P. Konstantinou, Michelle A. Lowes, Amanda S. MacLeod, Antonio Martorell, Angelo V. Marzano, Łukasz Matusiak, Aude Nassif, Elena Nikiphorou, Georgios Nikolakis, André Nogueira da Costa, Martin M. Okun, Lauren A.V. Orenstein, José Carlos Pascual, Ralf Paus, Benjamin Perin, Errol P. Prens, Till A. Röhn, Andrea Szegedi, Jacek C. Szepietowski, Thrasyvoulos Tzellos, Baoxi Wang & Hessel H. van der Zee. (2020) What causes hidradenitis suppurativa ?—15 years after. Experimental Dermatology 29:12, pages 1154-1170.
Crossref
Crossref
Elisa Molinelli, Federico Diotallevi, Oriana Simonetti, Valerio Brisigotti, Claudia Sapigni, Giulia Radi, Anna Campanati & Annamaria Offidani. (2020) Management of patients with hidradenitis suppurativa during the COVID‐19 pandemic: Risk and benefit of immunomodulatory therapy. Dermatologic Therapy 33:6.
Crossref
Crossref